$2.13 Billion is the total value of NEA Management Company, LLC's 43 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 9.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSRO | TESARO INC | $463,402,000 | -22.2% | 10,420,555 | 0.0% | 21.71% | -18.0% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCadr | $158,258,000 | +5.7% | 13,332,611 | 0.0% | 7.41% | +11.3% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $153,559,000 | +57.1% | 4,912,306 | 0.0% | 7.19% | +65.5% | |
| GLYC | Buy | GLYCOMIMETICS INC | $146,606,000 | +5.2% | 9,089,041 | +5.9% | 6.87% | +10.8% |
| MRSN | MERSANA THERAPEUTICS INC | $145,457,000 | +13.3% | 8,144,267 | 0.0% | 6.81% | +19.3% | |
| SENS | SENSEONICS HOLDINGS INC | $126,951,000 | +37.0% | 30,888,266 | 0.0% | 5.95% | +44.3% | |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $122,848,000 | -22.9% | 2,090,678 | -40.0% | 5.76% | -18.8% |
| EPZM | EPIZYME INC | $87,545,000 | -23.7% | 6,460,851 | 0.0% | 4.10% | -19.6% | |
| OBSV | OBSEVA SA | $69,441,000 | +12.2% | 4,586,563 | 0.0% | 3.25% | +18.2% | |
| ARDX | Buy | ARDELYX INC | $56,740,000 | -20.2% | 15,335,047 | +8.9% | 2.66% | -16.0% |
| RARX | RA PHARMACEUTICALS INC | $54,662,000 | +87.4% | 5,493,636 | 0.0% | 2.56% | +97.3% | |
| SURF | New | SURFACE ONCOLOGY INC | $54,070,000 | – | 3,315,149 | +100.0% | 2.53% | – |
| AKAOQ | ACHAOGEN INC | $45,163,000 | -33.1% | 5,215,128 | 0.0% | 2.12% | -29.6% | |
| SYBX | SYNLOGIC INC | $41,575,000 | +4.8% | 4,229,410 | 0.0% | 1.95% | +10.4% | |
| AVEO | Buy | AVEO PHARMACEUTICALS INC | $40,091,000 | -15.5% | 17,783,722 | +8.7% | 1.88% | -11.0% |
| DERM | DERMIRA INC | $32,261,000 | +15.1% | 3,506,649 | 0.0% | 1.51% | +21.3% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $28,587,000 | +40.0% | 2,382,286 | 0.0% | 1.34% | +47.5% | |
| CMTA | CLEMENTIA PHARMACEUTICALS IN | $28,185,000 | -13.1% | 2,141,697 | 0.0% | 1.32% | -8.5% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $27,072,000 | +8.5% | 4,808,483 | 0.0% | 1.27% | +14.2% | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $24,848,000 | -32.2% | 4,141,308 | 0.0% | 1.16% | -28.6% | |
| MEIP | New | MEI PHARMA INC | $22,539,000 | – | 5,720,572 | +100.0% | 1.06% | – |
| GNCA | GENOCEA BIOSCIENCES INC | $21,250,000 | -19.0% | 25,000,000 | 0.0% | 1.00% | -14.7% | |
| CTIC | CTI BIOPHARMA CORP | $18,675,000 | +27.7% | 3,750,000 | 0.0% | 0.88% | +34.4% | |
| VRNA | VERONA PHARMA PLCads | $16,661,000 | -31.7% | 1,219,674 | 0.0% | 0.78% | -28.0% | |
| PTI | PROTEOSTASIS THERAPEUTICS INC | $15,503,000 | -41.3% | 5,556,778 | 0.0% | 0.73% | -38.2% | |
| ELGX | ENDOLOGIX INC | $14,095,000 | +33.8% | 2,490,204 | 0.0% | 0.66% | +40.7% | |
| ARQL | ARQULE INC | $13,937,000 | +92.0% | 2,520,316 | 0.0% | 0.65% | +102.2% | |
| NITE | NIGHTSTAR THERAPEUTICS PLCadr | $11,429,000 | +11.8% | 714,285 | 0.0% | 0.54% | +17.6% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $9,906,000 | +74.2% | 1,562,500 | 0.0% | 0.46% | +83.4% | |
| TCON | TRACON PHARMACEUTICALS INC | $9,361,000 | +17.4% | 3,467,181 | 0.0% | 0.44% | +23.7% | |
| DZSI | DASAN ZHONE SOLUTIONS INC | $9,333,000 | -14.7% | 956,255 | 0.0% | 0.44% | -10.3% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $9,178,000 | -20.1% | 3,243,150 | 0.0% | 0.43% | -15.9% | |
| AFMD | AFFIMED NV | $8,479,000 | -10.8% | 5,138,888 | 0.0% | 0.40% | -6.1% | |
| TRILLIUM THERAPEUTICS INC | $7,500,000 | -16.7% | 1,250,000 | 0.0% | 0.35% | -12.2% | ||
| MDB | MONGODB INCcl a | $7,445,000 | +14.4% | 150,000 | 0.0% | 0.35% | +20.3% | |
| ASNS | ARSANIS INC | $7,260,000 | -84.1% | 2,000,000 | 0.0% | 0.34% | -83.3% | |
| RGLS | REGULUS THERAPEUTICS INC | $7,244,000 | -8.1% | 10,989,910 | 0.0% | 0.34% | -3.4% | |
| ERYP | ERYTECH PHARMA SAadr | $6,981,000 | -46.8% | 625,000 | 0.0% | 0.33% | -44.0% | |
| TRVN | TREVENA INC | $5,489,000 | -12.2% | 3,811,691 | 0.0% | 0.26% | -7.6% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $2,752,000 | -22.1% | 1,298,274 | 0.0% | 0.13% | -17.8% | |
| TNTRQ | TINTRI INC | $1,296,000 | -85.6% | 5,253,358 | 0.0% | 0.06% | -84.8% | |
| AKTX | AKARI THERAPEUTICS PLCadr | $882,000 | +7.2% | 452,167 | 0.0% | 0.04% | +10.8% | |
| AYTU | AYTU BIOSCIENCE INC | $12,000 | -58.6% | 44,908 | 0.0% | 0.00% | 0.0% | |
| AQ | Exit | AQUANTIA | $0 | – | -239,587 | -100.0% | -0.17% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -2,772,643 | -100.0% | -1.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.